Laser Photonics, together with Fonon Technologies, an affiliated company within the LASE Group of Companies, announced continued advancement of its Laser Shield Anti-Drone, LSAD, system following a direct engagement with U.S. Special Operations Command, SOCOM. The engagement provided the LASE Group with an opportunity to present LSAD's directed-energy counter-unmanned aerial system capabilities to SOCOM stakeholders and to discuss the platform's potential role in addressing the rapidly expanding threat posed by small unmanned aircraft systems.

8/24 09:00

Laser Photonics Subsidiary Secures $1.05M Pharmaceutical Order

Laser Photonics announced that its subsidiary, CMS Laser, has received a purchase order valued at approximately $1.05M from a U.S.-based pharmaceutical company for a TD-70 high-speed pharmaceutical tablet drilling system. The order represents a first-time purchase by this customer and marks the Company's entry into a new pharmaceutical manufacturing account, further extending CMS Laser's precision laser drilling franchise within one of the most quality-intensive and highly regulated end markets it serves.

7/30 15:30

Laser Photonics Files to Sell 5.23M Shares of Common Stock

Laser Photonics files to sell 5.23M shares of common stock for holders

7/23 09:00

Laser Photonics and Fonon Technologies Selected for Air Force Contract

Laser Photonics, together with Fonon Technologies, an affiliated company within the LASE Group of Companies, announced that Fonon Technologies has been selected by the U.S. Air Force 20th Contracting Squadron to advance to Phase 2 of the Shaw Air Force Base, AFB, Battle Lab Commercial Solutions Opening, CSO, process. The selection follows a successful evaluation of the Company's solution brief for its Laser Shield Anti-Drone technology under Areas of Interest AOI 2.1 and AOI 2.3. In the upcoming formal pitch session - required to be scheduled by July 24 and conducted no later than September 14, 2026 - Fonon Technologies will detail LSAD's technical design, field readiness, deployment schedule, Rough Order of Magnitude pricing, and intellectual property assertions. Successful completion of the pitch session positions the Company to receive invitations to submit full written contract proposals.

7/17 08:30

Laser Photonics Issues 2,528,572 Shares of Common Stock, Raising Approximately $2.5M

Laser Photonics announced the entry into definitive agreements for the immediate exercise of certain outstanding warrants to purchase up to an aggregate of 2,528,572 shares of common stock of the Company originally issued in April, having an exercise price of $0.975 per share. The shares of common stock issuable upon exercise of the warrants are registered pursuant to an effective registration statement on Form S-1. The gross proceeds to the Company from the exercise of the warrants are expected to be approximately $2.5M, prior to deducting placement agent fees and estimated offering expenses. H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering. In consideration for the immediate exercise of the warrants for cash, the Company will issue new unregistered Series A-7 warrants to purchase up to 800,000 shares of common stock and new unregistered Series A-8 warrants to purchase up to 4,257,144 shares of common stock. The new warrants will have an exercise price of $0.975 per share and will be exercisable immediately upon issuance. The Series A-7 new warrants will expire five years after the effective date of the Resale Registration Statement and the Series A-8 new warrants will expire twenty-four months after the effective date of the Resale Registration Statement. The offering is expected to close on or about July 20, subject to satisfaction of customary closing conditions.

Mehr Events anzeigen

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.